Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Similar Posts
Foshan Yiying Hygiene Products Co., Ltd. – 715548 – 10/10/2025
CGMP/Finished Pharmaceuticals/AdulteratedE6(R3) Good Clinical Practice (GCP)
The Food and Drug Administration is announcing the availability of a final guidance for industry entitled “E6(R3) Good Clinical Practice.” This revision incorporates flexible, risk-based approaches and embraces innovations in trial design, conduct, and technology.Kenil Healthcare Private Limited – 704786 – 06/12/2025
CGMP/Finished Pharmaceuticals/AdulteratedDerma Solution – 11/03/2025
Unapproved New Drugs/Misbranded/BotoxFDA in Brief: FDA warns company for putting consumers at risk through distribution of non-compliant and misbranded drug ingredients
FDA issued a warning letter to Professional Compounding Centers of America Inc. (PCCA) for receiving and distributing adulterated and misbranded active pharmaceutical ingredients (APIs).Toki Slimming Candy may be harmful due to hidden drug ingredients
Toki Slimming Candy may be harmful due to hidden drug ingredients. The Food and Drug Administration is advising consumers not to purchase or use Toki Slimming Candy, a product promoted and sold for weight loss on various websites, including www.eBay.com, and possibly in some retail stores.